3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
Rituximab
57
Cyclophosphamide
40
Vincristine
26
Prednisone
25
Doxorubicin
22
Cytarabine
18
Lenalidomide
17
Etoposide
17
Gemcitabine
12
Melphalan
8
Filgrastim
8
Cisplatin
8
zanubrutinib
7
Peripheral Blood Stem Cell Transplantation
7
Oxaliplatin
7
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
7
Methotrexate
7
Ifosfamide
7
Carmustine
7
R-CHOP protocol
6
fludarabine phosphate
5
Vindesine
5
Radiotherapy
5
Dexamethasone
5
Decitabine
5
Busulfan
5
ibrutinib
4
Methylprednisolone
4
Epirubicin
4
Cyclosporine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Large B-Cell, Diffuse
×
temsirolimus
×
Clear all
NCT01653067
2016-10-27
STORM
University Hospital Heidelberg
Phase 2
Unknown
88 enrolled